# CaliberCos Inc.: overview CWD · Nasdaq · CIK 1627282 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cwd.md) · [Financials](/companies/cwd/financials.md) · [Filings](/companies/cwd/filings.md) · [Insiders](/companies/cwd/insiders.md) Latest reported revenue: [$3.7m](/filings/0001627282-26-000058.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001627282-26-000058). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [7,400](/filings/0001627282-25-000157.md) | [4,500 d](/filings/0001627282-26-000015.md) | [3,500](/filings/0001627282-26-000034.md) | [4,100](/filings/0001627282-26-000058.md) | [3,500](/filings/0001627282-25-000157.md) | [4,000 d](/filings/0001627282-26-000015.md) | [4,100](/filings/0001627282-26-000034.md) | [3,700](/filings/0001627282-26-000058.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [2.0%](/filings/0001627282-25-000157.md) | [(253.1%) d](/filings/0001627282-26-000015.md) | [(125.9%)](/filings/0001627282-26-000034.md) | [(129.2%)](/filings/0001627282-26-000058.md) | [(124.9%)](/filings/0001627282-25-000157.md) | [(193.0%) d](/filings/0001627282-26-000015.md) | [(88.3%)](/filings/0001627282-26-000034.md) | [(90.8%)](/filings/0001627282-26-000058.md) | | Diluted EPS | $ per share | [0.12](/filings/0001627282-25-000157.md) | not reported | [(3.85)](/filings/0001627282-26-000034.md) | [(4.15)](/filings/0001627282-26-000058.md) | [(1.65)](/filings/0001627282-25-000157.md) | not reported | [(0.52)](/filings/0001627282-26-000034.md) | [(0.38)](/filings/0001627282-26-000058.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [84.0](/filings/0001627282-24-000039.md) | [20.6](/filings/0001627282-25-000028.md) | [20.9](/filings/0001627282-26-000015.md) | [15.2](/filings/0001627282-26-000015.md) | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | | Net margin | % | [2.4%](/filings/0001627282-24-000039.md) | [(61.7%)](/filings/0001627282-25-000028.md) | [(94.6%)](/filings/0001627282-26-000015.md) | [(143.4%)](/filings/0001627282-26-000015.md) | | Diluted EPS | $ per share | [0.11](/filings/0001627282-24-000039.md) | [(0.63)](/filings/0001627282-25-000028.md) | [(17.90)](/filings/0001627282-26-000015.md) | [(7.70)](/filings/0001627282-26-000015.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cwd/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $37.0k | 56,489 | | New +56,489 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $36.3k | 55,390 | | Reduced −10,333 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $23.9k | 36,497 | | Added +10,153 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $23.4k | 35,759 | | Unchanged | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $18.8k | 28,765 | | Added +6,986 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $13.5k | 20,604 | | Added +9,615 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $10.4k | 15,869 | | Added +12,425 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.0k | 4,610 | | Added +2,226 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $1.0k | 1,048 | | Unchanged | | [DecisionPoint Financial, LLC](/funds/1938514.md) | 2026-06-30 | $92 | 142 | | Unchanged | ## Recent filings [All 351 filings](/companies/cwd/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 13:13 ET | [8-K](/filings/0001627282-26-000076.md) | 7.01 Regulation FD disclosure | 0001627282-26-000076 | | 2026-10-19 | 16:05 ET | [8-K](/filings/0001627282-26-000074.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001627282-26-000074 | | 2026-09-15 | 18:30 ET | [8-K](/filings/0001627282-26-000070.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001627282-26-000070 | | 2026-08-27 | 14:54 ET | [8-K](/filings/0001627282-26-000067.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001627282-26-000067 | | 2026-08-26 | 17:27 ET | [8-K](/filings/0001627282-26-000065.md) | 3.01 Delisting notice | 0001627282-26-000065 | | 2026-08-14 | 12:21 ET | [8-K](/filings/0001627282-26-000060.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001627282-26-000060 | | 2026-08-14 | 18:33 ET | [10-Q](/filings/0001627282-26-000058.md) | Quarterly report, period 2026-06-30 | 0001627282-26-000058 | | 2026-08-13 | 16:39 ET | [8-K](/filings/0001627282-26-000054.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001627282-26-000054 | | 2026-08-04 | 15:28 ET | [8-K](/filings/0001627282-26-000047.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001627282-26-000047 | | 2026-07-17 | 14:05 ET | [8-K](/filings/0001627282-26-000044.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001627282-26-000044 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001627282-26-000015.md), filed Mar 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3d50a0e8-3e9e-46ca-a12d-a2c91db80172) ## About the filer - CIK: 1627282 - Tickers: CWD - Exchange: Nasdaq - SIC code: 6500 Real Estate - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:14 ET. No prices; not investment advice.